The University of Southampton
University of Southampton Institutional Repository

Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing

Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing
Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing
Classical fear conditioning involves pairing a neutral conditional stimulus (CS) with an aversive unconditional stimulus (US). Subsequent presentation of the CS alone induces fear responses. Acquisition of conditioned fear is thought to involve learning of the CS/US association, followed by memory consolidation. Recently we reported that the N1/P2 auditory evoked potential was enhanced by fear conditioning in humans. Diazepam 10 mg, given before CS/US pairing, prevented subsequent expression of fear potentiation when the response was elicited, 1 week later, in the presence of the CS. In this experiment, we examined whether this effect of diazepam was caused by disruption of the formation of CS/US associations or by disruption of consolidation. The benzodiazepine antagonist flumazenil was used to block the effect of diazepam either during the association period or during subsequent consolidation. Forty-two male volunteers (18-35 years) participated in two sessions separated by 7 days. In Session One, they ingested diazepam 10 mg or placebo: 60 minutes later they received flumazenil 1 mg or saline intravenously (i.v.). Then they received 20 presentations of a light (CS), 50% of which terminated with electric shock (US). This was followed by a second infusion of flumazenil or saline. Subjects received placebo/saline/saline (Group 1), diazepam/saline/saline (Group 2), diazepam/flumazenil/saline (Group 3) and diazepam/saline/flumazenil (Group 4). In Session Two, the CS was presented without the US; 50% of CS presentations terminated with a sound pulse; an equal number of sound pulses were presented without the CS. Auditory evoked potentials were recorded at Cz. In Session Two, CS presentation enhanced the auditory N1/P2 potential in placebo-treated subjects (Group 1). This enhancement was prevented by diazepam (Group 2). Flumazenil reversed diazepam's effect on fear potentiation if it was administered before conditioning (Group 3), but not if it was administered afterwards (Group 4). The results confirm that diazepam prevents the acquisition of fear conditioning in humans, and suggest that it disrupts the formation of CS/US associations, rather than the consolidation of fear memory.
flumazenil, electroshock, drug effects, gaba-a, agents, reference values, photic stimulation, administration & dosage, psychiatry, diazepam, evoked potentials, reaction time, adult, human, auditory, fear, association learning, pharmacology, double-blind method, male, startle reaction, classical, gaba antagonists, receptors, anti-anxiety agents, expression, time factors, somatosensory, drug administration schedule, humans, conditioning
0269-8811
93-101
Scaife, J.C.
00d58c30-28b3-4778-b76a-d4d9770f6100
Hou, R.H.
470bdcbc-93a9-4dad-aac5-26d455c34376
Samuels, E.R.
be1fd344-e73a-43da-aca8-33c6e21cb7f2
Baqui, F.
0edad7d0-a11f-4efa-a50e-a467696af37c
Langley, R.W.
579cc42e-972f-4422-952f-1c76ecc4b4e3
Bradshaw, C.M.
0baafd10-0e91-4113-b90b-27132bd77305
Szabadi, E.
cff688f8-264f-4ca3-a2c4-cb10930f1956
Scaife, J.C.
00d58c30-28b3-4778-b76a-d4d9770f6100
Hou, R.H.
470bdcbc-93a9-4dad-aac5-26d455c34376
Samuels, E.R.
be1fd344-e73a-43da-aca8-33c6e21cb7f2
Baqui, F.
0edad7d0-a11f-4efa-a50e-a467696af37c
Langley, R.W.
579cc42e-972f-4422-952f-1c76ecc4b4e3
Bradshaw, C.M.
0baafd10-0e91-4113-b90b-27132bd77305
Szabadi, E.
cff688f8-264f-4ca3-a2c4-cb10930f1956

Scaife, J.C., Hou, R.H., Samuels, E.R., Baqui, F., Langley, R.W., Bradshaw, C.M. and Szabadi, E. (2007) Diazepam-induced disruption of classically-conditioned fear-potentiation of late-latency auditory evoked potentials is prevented by flumazenil given before, but not after, CS/US pairing. Journal of Psychopharmacology, 21 (1), 93-101. (doi:10.1177/0269881106063130).

Record type: Article

Abstract

Classical fear conditioning involves pairing a neutral conditional stimulus (CS) with an aversive unconditional stimulus (US). Subsequent presentation of the CS alone induces fear responses. Acquisition of conditioned fear is thought to involve learning of the CS/US association, followed by memory consolidation. Recently we reported that the N1/P2 auditory evoked potential was enhanced by fear conditioning in humans. Diazepam 10 mg, given before CS/US pairing, prevented subsequent expression of fear potentiation when the response was elicited, 1 week later, in the presence of the CS. In this experiment, we examined whether this effect of diazepam was caused by disruption of the formation of CS/US associations or by disruption of consolidation. The benzodiazepine antagonist flumazenil was used to block the effect of diazepam either during the association period or during subsequent consolidation. Forty-two male volunteers (18-35 years) participated in two sessions separated by 7 days. In Session One, they ingested diazepam 10 mg or placebo: 60 minutes later they received flumazenil 1 mg or saline intravenously (i.v.). Then they received 20 presentations of a light (CS), 50% of which terminated with electric shock (US). This was followed by a second infusion of flumazenil or saline. Subjects received placebo/saline/saline (Group 1), diazepam/saline/saline (Group 2), diazepam/flumazenil/saline (Group 3) and diazepam/saline/flumazenil (Group 4). In Session Two, the CS was presented without the US; 50% of CS presentations terminated with a sound pulse; an equal number of sound pulses were presented without the CS. Auditory evoked potentials were recorded at Cz. In Session Two, CS presentation enhanced the auditory N1/P2 potential in placebo-treated subjects (Group 1). This enhancement was prevented by diazepam (Group 2). Flumazenil reversed diazepam's effect on fear potentiation if it was administered before conditioning (Group 3), but not if it was administered afterwards (Group 4). The results confirm that diazepam prevents the acquisition of fear conditioning in humans, and suggest that it disrupts the formation of CS/US associations, rather than the consolidation of fear memory.

This record has no associated files available for download.

More information

Published date: January 2007
Keywords: flumazenil, electroshock, drug effects, gaba-a, agents, reference values, photic stimulation, administration & dosage, psychiatry, diazepam, evoked potentials, reaction time, adult, human, auditory, fear, association learning, pharmacology, double-blind method, male, startle reaction, classical, gaba antagonists, receptors, anti-anxiety agents, expression, time factors, somatosensory, drug administration schedule, humans, conditioning

Identifiers

Local EPrints ID: 62568
URI: http://eprints.soton.ac.uk/id/eprint/62568
ISSN: 0269-8811
PURE UUID: a1d74274-056c-497c-a893-80d0a2461782
ORCID for R.H. Hou: ORCID iD orcid.org/0000-0001-6127-1478

Catalogue record

Date deposited: 07 Apr 2009
Last modified: 16 Mar 2024 03:55

Export record

Altmetrics

Contributors

Author: J.C. Scaife
Author: R.H. Hou ORCID iD
Author: E.R. Samuels
Author: F. Baqui
Author: R.W. Langley
Author: C.M. Bradshaw
Author: E. Szabadi

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×